Technical Data
Fibroblast Growth Factor 9, Recombinant, Human (FGF9)
Molecular Biology Storage: -20CShipping: Blue Ice
Recombinant corresponding to 207aa from human Fibroblast Growth Factor 9, expressed in E. coli

Molecular Weight:

ED50 <0.5 ng/ml (> 2 x 106units/mg), determined by the dose dependent stimulation of thymidine uptake by BaF3 cells expressing FGF-receptors. FGF-9 is a heparin binding growth factor that has principal activity in and on, nervous tissue. Cells known to express FGF-9 include prostatic stromal cells, neurons, astrocytes and oligodendrocytes and fetal skeletal myoblasts, ventricular myocardium, gut lumenal epithelium and olfactory bulb. It is also known as glial-activating factor (GAF).

Endotoxin: 0.1ng/ug

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with Tris, pH 8.0, sodium chloride. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Molecular Weight:
Source: E. coli
Purity: ~95% (SDS PAGE)
Concentration: Not determined
Form: Lyophilized from 10 mM Tris, pH 8.0, 50mM sodium chloride. Reconstitute with 10mM Tris, pH 8.0, 50 mM sodium chloride to 0.1-1.0 mg/ml.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
1. Giri, D. et al. (1999) J. Cell Physiol. 180:53. 2. Nakamura, S. et al. (1999) Glia 28:53. 3. Todo, T. et al. (1998) Brain Res. 783:179. 4. Colvin, J.S. et al. (1999) Dev. Dyn. 216:72.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.